Rituximab,nelarabine,Imatinib,Idarubicin
Novartis
['leusm', 'elara', 'nelarabine']
nicola g kbuget presents on pts w/ t-all/lbl in gmall trial 08/2013 -&gt; pts w/ molecular mrd post-consolidation 1 rec d nelarabine pre-hct &amp; others received as part of consolidation blocks 3/5. key findings: thymic t-all (cd1a+) remains lower-risk group (1/2) #ash22 #leusm #allsm 
Leukemia/cell therapy doc & AYA Leukemia Program Leader at @MSKCancerCenter w/ special interest in ALL. Indie rock & Boston sports fan. Opinions=my own.??????